Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Transpulmonary Pressure-Guided Ventilation for Right Heart Protection in ARDS

Official title: Application of Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With Acute Respiratory Distress Syndrome Caused by Pneumonia

Run by Beijing Chao Yang Hospital · NCT07490925 · Data updated 2026-11-12

This study tests whether using transpulmonary pressure to guide ventilation can reduce right heart involvement in adults with pneumonia-related moderate to severe ARDS.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorBeijing Chao Yang Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedMarch 23, 2026
Main results expectedMarch 31, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 14, 2026
Trial IDNCT07490925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with pneumonia-induced moderate to severe ARDS on invasive mechanical ventilation.

Probably not a fit

Patients with esophageal catheter contraindications or other high-risk factors may not benefit and could be at risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this interventional trial, researchers will apply a ventilation strategy guided by transpulmonary pressure to patients with pneumonia-induced ARDS and compare its effects on the right ventricle to the standard right-ventricle–protective approach. Eligible patients are adults with ARDS and PaO2/FiO2 ≤ 200 on invasive mechanical ventilation. The aim is to see if the transpulmonary-guided strategy lowers the incidence of acute cor pulmonale and other right-heart complications. The trial is conducted at Beijing Chao-Yang Hospital and involves careful monitoring and esophageal pressure measurement to tailor ventilator settings. Safety considerations include exclusion of patients with conditions that could confound measurements or increase risk, such as high intracranial pressure or active air leakage in the lungs.

Why it matters

Potential benefit: If successful, patients may experience better right-heart function and potentially improved outcomes during severe ARDS.

How similar studies have gone: Previous work in targeting transpulmonary pressure shows promise for lung protection; this study extends the approach to right-heart protection in ARDS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years old
2. ARDS caused by pneumonia (New Global Definition of ARDS)
3. PaO2/FiO2≤200mmHg
4. Received invasive mechanical ventilation
5. Sign the informed consent form

Exclusion Criteria:

1. Invasive mechanical ventilation duration \> 48 hours
2. History of pulmonary hypertension caused by various reasons
3. Severe arrhythmia
4. BMI\>30kg/m2
5. Contraindications to inserting an esophageal catheter (including recent esophageal injury or surgery, severe coagulopathy (platelets \< 5×10⁹/L or INR \> 4)
6. Pregnant and lactating women
7. Lung transplant recipient
8. High-risk factors for increased intracranial pressure (including intracranial hemorrhage, cerebral contusion, cerebral edema, intracranial space-occupying lesions, etc.)
9. Active air leakage in the lungs (pneumothorax, mediastinal emphysema, bronchopleural fistula, air leakage from closed thoracic drainage tubes, etc.)
10. Neuromuscular disease
11. Already received salvage measures (iNO, ECMO, prone position, high-frequency oscillatory ventilation)
12. Severe liver failure
13. Participated in other ARDS-related studies within 30 days

Where it's running

  • Beijing Chao-Yang Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.